{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:28:25Z","timestamp":1782905305837,"version":"3.54.5"},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T00:00:00Z","timestamp":1380672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jinf.2013.08.010","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T14:02:20Z","timestamp":1377180140000},"page":"497-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Antibiotics for treatment and prevention of\u00a0exacerbations of chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Robert","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Anzueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2013.08.010_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","article-title":"Global burden of COPD: risk factors, prevalence, and future trends","volume":"370","author":"Mannino","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2013.08.010_bib2","series-title":"Chronic obstructive pulmonary disease data fact sheet","author":"NHLBI","year":"2003"},{"key":"10.1016\/j.jinf.2013.08.010_bib3","series-title":"Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach","isbn-type":"print","year":"2007","ISBN":"https:\/\/id.crossref.org\/isbn\/9789241563468"},{"key":"10.1016\/j.jinf.2013.08.010_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1378\/chest.07-1131","article-title":"COPD in Asia: where east meets west","volume":"133","author":"Tan","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib5","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"16","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11908-012-0255-7","article-title":"Relation between chronic obstructive pulmonary disease and antibiotics","volume":"14","author":"Sialer","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jinf.2013.08.010_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thorax.58.7.589","article-title":"Time course of recovery of health status following an infective exacerbation of chronic bronchitis","volume":"58","author":"Spencer","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1378\/chest.123.3.784","article-title":"Costs of chronic bronchitis and COPD: a 1-year follow-up study","volume":"123","author":"Miravitlles","year":"2003","journal-title":"Chest"},{"issue":"7245","key":"10.1016\/j.jinf.2013.08.010_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2013.08.010_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","article-title":"Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease","volume":"22","author":"Calverley","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib14","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib15","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1183\/09058180.05.00009404","article-title":"Treatment of COPD exacerbations: antibiotics","volume":"14","author":"Wilson","year":"2005","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jinf.2013.08.010_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1183\/09031936.00042111","article-title":"Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis","volume":"39","author":"Miravitlles","year":"2012","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jinf.2013.08.010_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"issue":"Suppl. A","key":"10.1016\/j.jinf.2013.08.010_bib19","first-page":"1A","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care","volume":"15","author":"O'Donnell","year":"2008","journal-title":"Can Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib20","series-title":"Global strategy for the diagnosis, management and prevention of COPD","author":"GOLD","year":"2011"},{"issue":"Suppl. 6","key":"10.1016\/j.jinf.2013.08.010_bib21","first-page":"E1","article-title":"Guidelines for the management of adult lower respiratory tract infections \u2013 full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Mirobiol Infect"},{"key":"10.1016\/j.jinf.2013.08.010_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1183\/09031936.00088108","article-title":"Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD","volume":"33","author":"Roede","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1378\/chest.117.5.1345","article-title":"Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD","volume":"117","author":"Adams","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib24","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa023161","article-title":"Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease","volume":"348","author":"Aaron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thorax.58.8.680","article-title":"Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis","volume":"58","author":"White","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.200906-0837OC","article-title":"Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"181","author":"Daniels","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1164\/rccm.201206-0996OC","article-title":"Efficacy of antibiotic therapy for acute exacerbations of mild to moderate COPD","volume":"186","author":"Llor","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00090311","article-title":"Moxifloxacin vs amoxicillin\/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results","volume":"40","author":"Wilson","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2013.08.010_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200807-1067OC","article-title":"Temporal clustering of exacerbations in chronic obstructive pulmonary disease","volume":"179","author":"Hurst","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0149-2918(02)85139-6","article-title":"A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes","volume":"24","author":"Wilson","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2013.08.010_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory changes, recovery and recurrence at COPD exacerbation","volume":"29","author":"Perera","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00081409","article-title":"Infection as a comorbidity of COPD","volume":"35","author":"Sethi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1183\/09031936.04.00056804","article-title":"Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD","volume":"23","author":"Banerjee","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","article-title":"Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease","volume":"167","author":"Wilkinson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/rccm.200509-1525OC","article-title":"Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease","volume":"173","author":"Sethi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/15412555.2011.636407","article-title":"Effect of bronchial colonisation on airway and systemic inflammation in stable COPD","volume":"9","author":"Marin","year":"2012","journal-title":"COPD"},{"key":"10.1016\/j.jinf.2013.08.010_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD. Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Resp Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib41","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in patients with COPD","volume":"140","author":"Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib42","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00330-003-1821-z","article-title":"Diagnosis of bronchiectasis with multislice spiral CT: accuracy of 3-mm-thick structured sections","volume":"13","author":"Remy-Jardin","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jinf.2013.08.010_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/thx.52.3.260","article-title":"Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study","volume":"52","author":"Miszkiel","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1155\/2011\/139493","article-title":"Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients","volume":"31","author":"Paone","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.jinf.2013.08.010_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.jinf.2013.08.010_bib47","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(01)07097-0","article-title":"Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial","volume":"358","author":"Nouira","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2013.08.010_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/pupt.2001.0289","article-title":"Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study","volume":"14","author":"Allegra","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"issue":"Suppl. A","key":"10.1016\/j.jinf.2013.08.010_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/37.suppl_A.93","article-title":"Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study","volume":"27","author":"Allegra","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2013.08.010_bib50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1742-1241.1999.tb11810.x","article-title":"Cefaclor versus amoxicillin\/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study","volume":"53","author":"Bandak","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jinf.2013.08.010_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/rmed.1999.0708","article-title":"Short course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis","volume":"94","author":"Chodosh","year":"2000","journal-title":"Resp Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/rmed.2000.0927","article-title":"The safety and efficacy of short course (5 day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbations of chronic bronchitis","volume":"94","author":"DeAbate","year":"2000","journal-title":"Resp Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib53","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0149-2918(02)80045-5","article-title":"Open-label, randomized comparison of clarithromycin, levofloxacin and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis","volume":"24","author":"Weiss","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2013.08.010_bib54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.rmed.2006.01.013","article-title":"Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latine American cohort","volume":"100","author":"Urueta-Robledo","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib55","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.125.3.953","article-title":"Short and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis","volume":"125","author":"Wilson","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1179\/joc.2002.14.6.597","article-title":"Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB)","volume":"14","author":"Grassi","year":"2002","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2013.08.010_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2006.11.033","article-title":"Levofloxacin 500\u00a0mg once daily versus cefuroxime 250\u00a0mg twice daily in patients with acute exacerbations of chronic obstructive bronchitits: clinical efficacy and exacerbation-free interval","volume":"30","author":"Petitpretz","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2013.08.010_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1440-1843.2006.00950.x","article-title":"Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Ruiz-Gonzalez","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.jinf.2013.08.010_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.04.00009604","article-title":"Evaluation of therapy-free interval in COPD patients study group. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval","volume":"24","author":"Lode","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/514934","article-title":"Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis","volume":"27","author":"Chodosh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2013.08.010_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/653527","article-title":"Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease; a randomised trial of trimethoprim-sulfamethoxazole versus ciprofloxacin","volume":"51","author":"Nouira","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2013.08.010_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.00137006","article-title":"Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies","volume":"31","author":"Snoeck-Stroband","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib63","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1183\/09031936.01.99114901","article-title":"Changes in bronchial inflammation during acute exacerbations of chronic bronchitis","volume":"17","author":"Gompertz","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.164.1.2007050","article-title":"Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants","volume":"164","author":"Zhu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200404000-00008","article-title":"New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease","volume":"17","author":"Sethi","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2013.08.010_bib66","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib68","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ppul.20097","article-title":"Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease","volume":"38","author":"Murphy","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jinf.2013.08.010_bib69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0007-0971(87)90161-6","article-title":"Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa","volume":"81","author":"Stead","year":"1987","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib70","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/19.6.831","article-title":"Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection","volume":"19","author":"Jensen","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2013.08.010_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00006454-199701000-00032","article-title":"Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis","volume":"16","author":"Schaad","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2013.08.010_bib72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib73","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib74","first-page":"73","article-title":"Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis","volume":"525","author":"Hashiba","year":"1996","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.jinf.2013.08.010_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mhn.2002.124849","article-title":"One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide","volume":"126","author":"Cervin","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jinf.2013.08.010_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib77","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.rmed.2011.01.009","article-title":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105","author":"Serisier","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib78","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jinf.2013.08.010_bib79","first-page":"CD004105","article-title":"Prophylactic antibiotic therapy for chronic bronchitis","author":"Staykova","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jinf.2013.08.010_bib80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/COPD.S1189","article-title":"Use of azithromycin in the treatment of acute exacerbations of COPD","volume":"3","author":"Milstone","year":"2008","journal-title":"Int J COPD"},{"key":"10.1016\/j.jinf.2013.08.010_bib81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00151829-200403010-00007","article-title":"The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial","volume":"3","author":"Banerjee","year":"2004","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pupt.2009.12.002","article-title":"Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy","volume":"23","author":"Blasi","year":"2010","journal-title":"Pulmon Phamacol Ther"},{"key":"10.1016\/j.jinf.2013.08.010_bib84","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"He","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.jinf.2013.08.010_bib85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/COPD.S23655","article-title":"Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations","volume":"6","author":"Pomares","year":"2011","journal-title":"Int J COPD"},{"key":"10.1016\/j.jinf.2013.08.010_bib86","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib88","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00195608","article-title":"Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD","volume":"34","author":"Miravitlles","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib89","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arbres.2012.04.001","article-title":"Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jinf.2013.08.010_bib91","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jinf.2013.08.010_bib92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jinf.2013.08.010_bib93","first-page":"479","article-title":"Aerosolized antibiotics in cystic fibrosis: current and future trends","volume":"2","author":"Fiel","year":"2008","journal-title":"Exp Rev Resp Med"},{"issue":"Suppl. 3","key":"10.1016\/j.jinf.2013.08.010_bib94","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.120.3_suppl.114S","article-title":"Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa","volume":"120","author":"Couch","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib95","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/08942680152007909","article-title":"Aerosols and anti-infectious agents","volume":"14","author":"Diot","year":"2001","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib97","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1378\/chest.120.3_suppl.94S","article-title":"Formulation of aerosolized therapeutics","volume":"120","author":"Kuhn","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.3.1.71","article-title":"Aerosolised antibiotics: a critical appraisal of their use","volume":"3","author":"Hagerman","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jinf.2013.08.010_bib99","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.65.6.650","article-title":"Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study","volume":"65","author":"Klastersky","year":"1974","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1378\/chest.75.5.586","article-title":"Endotracheally administered antibiotics for gram-negative bronchopneumonia","volume":"75","author":"Klastersky","year":"1979","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.34.2.269","article-title":"Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia","volume":"34","author":"Brown","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2013.08.010_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00003246-199801000-00013","article-title":"Aerosolized antibiotics in mechanically ventilated patients: delivery and response","volume":"26","author":"Palmer","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000542-200207000-00028","article-title":"Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia","volume":"97","author":"Elman","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jinf.2013.08.010_bib104","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2013.08.010_bib105","article-title":"A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI","author":"Griese","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2013.08.010_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00148581-200709001-00003","article-title":"Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa","volume":"9","author":"Lenoir","year":"2007","journal-title":"Paediatr Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2013.08.010_bib107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00148581-200709001-00004","article-title":"A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study","volume":"9","author":"Chuchalin","year":"2007","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jinf.2013.08.010_bib108","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib109","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcf.2008.06.009","article-title":"Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience","volume":"7","author":"Hansen","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jinf.2013.08.010_bib111","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2013.08.010_bib112","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/jac\/dkr303","article-title":"Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)","volume":"66","author":"Oermann","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2013.08.010_bib113","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ppul.21356","article-title":"Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial","volume":"46","author":"Konstan","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jinf.2013.08.010_bib114","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jinf.2013.08.010_bib115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcf.2011.02.007","article-title":"Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa","volume":"10","author":"Wainwright","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jinf.2013.08.010_bib116","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/thoraxjnl-2012-202230","article-title":"Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection","volume":"68","author":"Clancy","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2013.08.010_bib117","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12325-008-0105-2","article-title":"Tobramycin nebulizer solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation","volume":"25","author":"Dal Negro","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.jinf.2013.08.010_bib118","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1183\/09031936.00003309","article-title":"Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study","volume":"34","author":"Garcia-Vidal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib119","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.06.00074605","article-title":"The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis","volume":"28","author":"Davies","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2013.08.010_bib120","first-page":"A3037","article-title":"A Phase 2 study to evaluate the safety, tolerability and efficacy of levofloxacin inhalation solution (MP-376) administered for 5 days every 28 days to prevent acute exacerbations in high risk COPD patients","volume":"185","author":"Sethi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2013.08.010_bib121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/13543784.2013.748034","article-title":"MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections","volume":"22","author":"Azoicai","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jinf.2013.08.010_bib122","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00002512-200219100-00005","article-title":"Chronic obstructive pulmonary disease. Role of bacteria and guide to antibacterial selection in the older patient","volume":"19","author":"Murphy","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jinf.2013.08.010_bib123","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/13543784.11.7.911","article-title":"Antibiotics in the treatment of acute exacerbations of chronic bronchitis","volume":"11","author":"Dever","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jinf.2013.08.010_bib124","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00044011-200727020-00002","article-title":"Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting","volume":"27","author":"Miravitlles","year":"2007","journal-title":"Clin Drug Invest"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445313002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445313002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:18:48Z","timestamp":1759007928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445313002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0163445313002429"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2013.08.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics for treatment and prevention of\u00a0exacerbations of chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2013.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}